There is a great number of firms which give an invitation to the customers for swabbing their cheeks, spitting into a container, and then find the suitable antidepressant for them.
The main aim of their products; pharmacogenomics tests, is to predict the way by which someone suffering from depression will respond to the medications given depending upon the genetic makeup of the person, eliminating them from the trial and error which frequently comes with the selection of their antidepressant. A few firms like Color Genomics have a requirement of an order of test by the physician. However, the order of many of the testing products can be placed by the consumers directly. A couple of them have been approved by the Food and Drug Administration.
Although the psychiatrists think of these tests as very effective, the majority of the doctors have issued warnings against the ones available in the market. They state that masses of genes might have an impact on the depression, and there is a lack of studies which demonstrate the benefits of these tests.
Depression is highly prevalent and is considered as the most common mental disorder in the US. Two years back, a predicted 17.3M adults in the US reportedly experienced at least one depressing drive in their life, proposing that they have had a depressed mood. Nearly half of them sought treatment with medication, as revealed by the National Institute of Mental Health.
However, in the positive light, common antidepressants might take more than 6 six weeks to show their effects. More frequently, patients give a try to various medications over the course of months, testing a combination of treatment with the consultancy of their doctor. In the meantime, these individuals might go through some unpleasant side effects, such as gain in weight and dry mouth.